According to Dermapharm's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.47894. At the end of 2023 the company had a P/S ratio of 2.05.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.05 | 0.87% |
2022 | 2.03 | -59.11% |
2021 | 4.96 | 20.39% |
2020 | 4.12 | 33.38% |
2019 | 3.09 | 50.46% |
2018 | 2.05 |